Literature DB >> 7666508

Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region.

M E Jackson1, M S Campo.   

Abstract

The bovine papillomavirus type 4 (BPV4) long control region (LCR) contains three consensus binding sites, E2(1), E2(2), and E2(3) (ACCN6GGT), for the viral E2 transcription factor and a fourth degenerate site, dE2 (ATCN6GGT), which lies 3 bp upstream of E2(3). The E2(2) site was found to bind the cellular transcription factor PEBP2, and mutations at this site reduced basal promoter activity by as much as 60%, indicating an important role for PEBP2 in LCR function. Mutation of the E2(3) or dE2 site slightly decreased basal promoter activity, but the cellular proteins binding these sites have not yet been characterized. E2 protein was found to have considerable influence upon LCR promoter activity in primary bovine palate keratinocytes. Thus, when high levels of BPV1 E2 were present, almost complete repression of the BPV4 LCR was observed, whereas smaller amounts of BPV1 or BPV4 E2 led to transactivation. Mutational analysis indicated that E2(1) and dE2 mediated transactivation by E2, whereas E2(2) and E2(3) were responsible for repression by E2. In vitro complexes of binding sites E2(1) and E2(2) with E2 protein demonstrated much greater stability than complexes formed by the E2(3) and dE2 sites. These data suggest that the four E2 sites in the BPV4 LCR each perform different functions in the control of transcription and that competition between cellular transcription factors and viral E2 proteins is essential in regulating the level of viral gene expression during papilloma development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666508      PMCID: PMC189500     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor.

Authors:  S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts.

Authors:  R T Jaggar; W D Pennie; K T Smith; M E Jackson; M S Campo
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

3.  Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer.

Authors:  Y Kamachi; E Ogawa; M Asano; S Ishida; Y Murakami; M Satake; Y Ito; K Shigesada
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design.

Authors:  E A Golemis; N A Speck; N Hopkins
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor.

Authors:  A Stenlund; M R Botchan
Journal:  Genes Dev       Date:  1990-01       Impact factor: 11.361

6.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.

Authors:  A R Brasier; J E Tate; J F Habener
Journal:  Biotechniques       Date:  1989 Nov-Dec       Impact factor: 1.993

7.  The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.

Authors:  B Gloss; H U Bernard
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.

Authors:  H Romanczuk; F Thierry; P M Howley
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus.

Authors:  R Fulton; M Plumb; L Shield; J C Neil
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

10.  Protein recognition sites in polyomavirus enhancer: formation of a novel site for NF-1 factor in an enhancer mutant and characterization of a site in the enhancer D domain.

Authors:  M Caruso; C Iacobini; C Passananti; A Felsani; P Amati
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  9 in total

1.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.

Authors:  H M Schmidt; G Steger; H Pfister
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.

Authors:  E C Goodwin; L K Naeger; D E Breiding; E J Androphy; D DiMaio
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.

Authors:  B Rapp; A Pawellek; F Kraetzer; M Schaefer; C May; K Purdie; K Grassmann; T Iftner
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.

Authors:  K W Vance; M S Campo; I M Morgan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Identification of TAZ as a binding partner of the polyomavirus T antigens.

Authors:  Yu Tian; Dawei Li; Jean Dahl; John You; Thomas Benjamin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.

Authors:  G Steger; S Corbach
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.

Authors:  A Nishimura; T Ono; A Ishimoto; J J Dowhanick; M A Frizzell; P M Howley; H Sakai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 9.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.